Key statistics
As of last trade Longboard Pharmaceuticals Inc (LBPH:NMQ) traded at 35.05, -18.78% below its 52-week high of 43.15, set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.16 |
---|---|
High | 36.93 |
Low | 33.81 |
Bid | 34.95 |
Offer | 35.15 |
Previous close | 36.22 |
Average volume | 936.29k |
---|---|
Shares outstanding | 38.90m |
Free float | 33.84m |
P/E (TTM) | -- |
Market cap | 1.41bn USD |
EPS (TTM) | -2.16 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 17:10 BST.
More ▼
Press releases
- Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome
- Longboard Pharmaceuticals Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Bexicaserin (LP352) in Dravet Syndrome
- Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
- Longboard Pharmaceuticals to Participate in Four Upcoming Investor Conferences in September
- Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress
- Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on September 16, 2024
- Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1
More ▼